Glioblastoma Clinical Trials in Tampa, FL

Glioblastoma Clinical Trials in Tampa, FL

View the best 10 glioblastoma medical studies in Tampa, Florida. Access promising new therapies by applying to a Tampa-based Glioblastoma clinical trial.

Trials in Tampa, Florida

Here are the top 9 medical studies for glioblastoma in Tampa, Florida

Image of Illinois CancerCare-Bloomington in Bloomington, United States.

Atezolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial tests a combination of tocilizumab, atezolizumab, and precise radiation therapy in patients with recurrent glioblastoma. Tocilizumab reduces inflammation, atezolizumab boosts the immune system, and the radiation targets the tumor. The goal is to make the tumor more responsive to treatment and improve patient outcomes.
Image of Children's Hospital of Alabama in Birmingham, United States.

Radiation Therapy

Radiation

Recruiting1 awardPhase 2
This trial studies how well dabrafenib and trametinib work after radiation therapy in children and young adults with a specific type of brain tumor. These drugs help stop tumor growth by blocking signals that tell the cells to multiply. Dabrafenib has been developed and tested extensively for a specific type of skin cancer, showing effectiveness both alone and when used with trametinib.
Image of Children's Hospital of Alabama in Birmingham, United States.

Selpercatinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial will test how well selpercatinib works in treating patients with advanced solid tumors, lymphomas, or histiocytic disorders that have activating RET gene alterations.
Image of University of Maryland, Baltimore & The University of Maryland Medical System in Baltimore, United States.

Exablate Model 4000

Focused Ultrasound

Recruiting1 award
This trial aims to test the safety and effectiveness of using the Exablate device to temporarily open the blood-brain barrier in patients with suspected Glioblastoma. By doing this, doctors can collect fluid from the brain to check for cancer cells. The study will take place at up to 25 centers in the US.
Image of Children's Oncology Group in Philadelphia, United States.

Selinexor +1 More

Selective Inhibitors of Nuclear Export

Recruiting1 awardPhase 1 & 2
This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Image of START Midwest, LLC in Grand Rapids, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug called NGM707, both by itself and with another drug, Pembrolizumab. It targets patients with very advanced or spreading solid tumors. The treatment aims to boost the immune system to better fight cancer.
Image of University of Alabama at Birmingham in Birmingham, United States.

OKN-007 +1 More

Chemotherapy

Recruiting1 awardPhase 2
This trial is testing a new drug called OKN-007 combined with a chemotherapy drug, temozolomide, in patients whose brain cancer has returned after standard treatments. OKN-007 may help reduce tumor growth and make the chemotherapy more effective. Temozolomide is effective in treating malignant brain tumors.
Image of City of Hope ( Site 0002) in Duarte, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial will test a combination of two drugs to see if it is safe and effective for treating various types of cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Ipilimumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding immunotherapy to radiation therapy can help people with newly diagnosed glioblastoma that has an unmethylated MGMT.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.